Temporal Horn Index and Volume of Medial Temporal Lobe Atrophy Using a New Semiautomated Method for Rapid and Precise Assessment

References

1. ↵
   McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 1984;34:939–44

   Abstract/FREE Full Text
2. ↵
   Kazee AM, Eskin TA, Lapham LW, et al. Clinicopathologic correlates in Alzheimer disease: assessment of clinical and pathologic diagnostic criteria. Alzheimer Dis Assoc Disord 1993;7:152–64

   PubMedWeb of Science
3. ↵
   Tierney MC, Fisher RH, Lewis AJ, et al. The NINCDS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer’s disease: a clinicopathologic study of 57 cases. Neurology 1988;38:359–64

   Abstract/FREE Full Text
4. ↵
   Seab JP, Jagust WJ, Wong ST, et al. Quantitative NMR measurements of hippocampal atrophy in Alzheimer’s disease. Magn Reson Med 1988;8:200–08

   PubMedWeb of Science
5. Kesslak JP, Nalcioglu O, Cotman CW. Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer’s disease. Neurology 1991;41:51–54

   Abstract/FREE Full Text
6. ↵
   Jack CR Jr, Petersen RC, O’Brien PC, et al. MR-based hippocampal volumetry in the diagnosis of Alzheimer’s disease. Neurology 1992;42:183–88

   Abstract/FREE Full Text
7. ↵
   de Leon MJ, George AE, Golomb J, et al. Frequency of hippocampal formation atrophy in normal aging and Alzheimer’s disease. Neurobiol Aging 1997;18:1–11

   PubMed
8. Nagy Z, Hindley NJ, Braak H, et al. The progression of Alzheimer’s disease from limbic regions to the neocortex: clinical, radiological and pathological relationships. Dement Geriatr Cogn Disord 1999;10:115–20

   CrossRefPubMedWeb of Science
9. ↵
   Smith AD, Jobst KA. Use of structural imaging to study the progression of Alzheimer’s disease. Br Med Bull 1996;52:575–86

   Abstract/FREE Full Text
10. ↵
    Shen D, Moffat S, Resnick SM, et al. Measuring size and shape of the hippocampus in MR images using a deformable shape model. Neuroimage 2002;15:422–34

    CrossRefPubMed
11. ↵
    Hogan RE, Mark KE, Wang L, et al. Mesial temporal sclerosis and temporal lobe epilepsy: MR imaging deformation-based segmentation of the hippocampus in five patients. Radiology 2000;216:291–97

    PubMedWeb of Science
12. ↵
    Geuze E, Vermetten E, Bremner JD. MR-based in vivo hippocampal volumetrics: 1. Review of methodologies currently employed. Mol Psychiatry 2005;10:147–59

    CrossRefPubMedWeb of Science
13. ↵
    Hahn HK, Rexilius J, Schlüter M. Fast and robust quantification of parahippocampal atrophy via temporal horn index. In: Tolxdorff T, Braun J, Handels H, et al, eds. Bildverarbeitung für die Medizin 2004: Algorithmen—Systeme—Anwendungen. Berlin: Springer-Verlag;2004 :371–75. Available at: http://ftp.informatik.rwth-aachen.de/Publications/CEUR-WS/Vol-116/p371.pdf
14. ↵
    Schroder J, Kratz B, Pantel J, et al. Prevalence of mild cognitive impairment in an elderly community sample. J Neural Transm Suppl 1998;54:51–59

    PubMed
15. ↵
    Reisberg B, Ferris SH, de Leon MJ, et al. The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry 1982;139:1136–39

    PubMedWeb of Science
16. ↵
    Levy R. Aging-associated cognitive decline. Working Party of the International Psychogeriatric Association in collaboration with the World Health Organization. Int Psychogeriatr 1994;6:63–68

    CrossRefPubMed
17. ↵
    Hahn HK, Millar WS, Klinghammer O, et al. A reliable and efficient method for cerebral ventricular volumetry in pediatric neuroimaging. Methods Inf Med 2004;43:376–82

    PubMedWeb of Science
18. ↵
    Hahn HK, Peitgen HO. IWT—Interactive watershed transform: a hierarchical method for efficient interactive and automated segmentation of multidimensional gray-scale images. Proc SPIE 2003;5032:643–53.

    CrossRef
19. ↵
    Parnetti L, Lowenthal DT, Presciutti O, et al. 1H-MRS, MRI-based hippocampal volumetry, and 99mTc-HMPAO-SPECT in normal aging, age-associated memory impairment, and probable Alzheimer’s disease. J Am Geriatr Soc 1996;44:133–38

    PubMedWeb of Science
20. ↵
    Juottonen K, Laakso MP, Partanen K, et al. Comparative MR analysis of the entorhinal cortex and hippocampus in diagnosing Alzheimer disease. AJNR Am J Neuroradiol 1999;20:139–44

    Abstract/FREE Full Text
21. ↵
    Jack CR Jr, Petersen RC, Xu YC, et al. Medial temporal atrophy on MRI in normal aging and very mild Alzheimer’s disease. Neurology 1997;49:786–94

    Abstract/FREE Full Text
22. ↵
    Thacker NA, Varma AR, Bathgate D, et al. Dementing disorders: volumetric measurement of cerebrospinal fluid to distinguish normal from pathologic findings—feasibility study. Radiology 2002;224:278–85

    PubMed
23. ↵
    Jack CR Jr, Petersen RC, Xu Y, et al. Rate of medial temporal lobe atrophy in typical aging and Alzheimer’s disease. Neurology 1998;51:993–99

    Abstract/FREE Full Text
24. ↵
    Frisoni GB, Beltramello A, Weiss C, et al. Linear measures of atrophy in mild Alzheimer disease. AJNR Am J Neuroradiol 1996;17:913–23

    Abstract
25. ↵
    Dahlbeck JW, McCluney KW, Yeakley JW, et al. The interuncal distance: a new MR measurement for the hippocampal atrophy of Alzheimer disease. AJNR Am J Neuroradiol 1991;12:931–32

    FREE Full Text
26. ↵
    Soininen H, Puranen M, Riekkinen PJ. Computed tomography findings in senile dementia and normal aging. J Neurol Neurosurg Psychiatry 1982;45:50–54

    Abstract/FREE Full Text
27. Scheltens P, Leys D, Barkhof F, et al. Atrophy of medial temporal lobes on MRI in “probable” Alzheimer’s disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry 1992;55:967–72

    Abstract/FREE Full Text
28. Erkinjuntti T, Lee DH, Gao F, et al. Temporal lobe atrophy on magnetic resonance imaging in the diagnosis of early Alzheimer’s disease. Arch Neurol 1993;50:305–10

    CrossRefPubMedWeb of Science
29. ↵
    Frisoni GB, Geroldi C, Beltramello A, et al. Radial width of the temporal horn: a sensitive measure in Alzheimer disease. AJNR Am J Neuroradiol 2002;23:35–47

    Abstract/FREE Full Text
30. ↵
    Jack CR Jr, Slomkowski M, Gracon S, et al. MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD. Neurology 2003;60:253–60

    Abstract/FREE Full Text
31. ↵
    Morris JC, Storandt M, McKeel DW Jr, et al. Cerebral amyloid deposition and diffuse plaques in “normal” aging: Evidence for presymptomatic and very mild Alzheimer’s disease. Neurology 1996;46:707–19

    FREE Full Text
32. ↵
    Petrella JR, Coleman RE, Doraiswamy PM. Neuroimaging and early diagnosis of Alzheimer disease: a look to the future. Radiology 2003;226:315–36

    PubMedWeb of Science
33. ↵
    Pantel J, Kratz B, Essig M, et al. Parahippocampal volume deficits in subjects with aging-associated cognitive decline. Am J Psychiatry 2003;160:379–82

    CrossRefPubMedWeb of Science
34. Soininen HS, Partanen K, Pitkanen A, et al. Volumetric MRI analysis of the amygdala and the hippocampus in subjects with age-associated memory impairment: correlation to visual and verbal memory. Neurology 1994;44:1660–68

    Abstract/FREE Full Text
35. Laakso MP, Partanen K, Lehtovirta M, et al. MRI of amygdala fails to diagnose early Alzheimer’s disease. Neuroreport 1995;6:2414–18

    PubMedWeb of Science
36. ↵
    Laakso MP, Soininen H, Partanen K, et al. MRI of the hippocampus in Alzheimer’s disease: sensitivity, specificity, and analysis of the incorrectly classified subjects. Neurobiol Aging 1998;19:23–31

    CrossRefPubMedWeb of Science